News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactLog in
Book a Demo
Foresight logo
All News & Insights

Belgium Completes Evaluation of Climbazole Under REACH Regulation

REACH
11
December 2024
•
350
Dr Steven Brennan
Belgium finalises REACH evaluation of climbazole, confirming its endocrine disruption and aquatic toxicity classification. Regulatory updates expected by 2025.
Cosmetics
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

Belgium has concluded its evaluation of climbazole under REACH, confirming its classification as an environmental endocrine disruptor and aquatic hazard. No significant consumer safety risks were identified, but regulatory updates for harmonised classification are imminent.

What is climbazole used for?

Climbazole is an antifungal agent primarily used in cosmetic products, such as anti-dandruff shampoos and skin creams.

What are the main concerns about climbazole?

The substance is classified as an endocrine disruptor for the environment and poses significant aquatic toxicity, necessitating updated regulatory measures​​.

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

The Belgian Federal Public Service has finalised the evaluation of climbazole (EC 253-775-4, CAS 38083-17-9) under the EU’s REACH regulation as of 4 November 2024. The substance, commonly used in cosmetics, was assessed for potential risks, including endocrine disruption and aquatic toxicity.

Key Findings of the Evaluation

Belgium, following an earlier review by the UK, concluded that climbazole poses no immediate consumer or wide-dispersive use concerns at the EU level. However, evidence confirmed its classification as an endocrine disruptor for the environment. It will now undergo harmonised classification and labelling under the EU’s regulatory framework​​.

Regulatory Outcomes and Recommendations

The evaluation highlighted several regulatory actions:

  • Endocrine Disruption: Climbazole meets the criteria for environmental endocrine disruption (ED ENV 1). Effects include disrupted steroidogenesis in aquatic species, impacting reproduction​.
  • Aquatic Toxicity: Classified as both acute (H400) and chronic (H410) aquatic hazard with a high concern for environmental persistence​​.
  • Consumer and Worker Safety: No significant risks were identified under current cosmetic use concentrations (0.5% as a preservative), indicating sufficient consumer safety measures​​.

Background and Process

Initially listed in the Community Rolling Action Plan (CoRAP) in 2014, climbazole was selected due to suspected carcinogenic, mutagenic, or reproductive toxicity (CMR), as well as widespread consumer use. The evaluation involved extensive testing, including a Fish Sexual Development Test (OECD TG 234), which confirmed endocrine effects​​.

Implications for Industry

The regulatory process may lead to a harmonised classification in Annex VI of the CLP Regulation by early 2025. Manufacturers and formulators using climbazole in personal care products must adhere to updated labelling and risk management protocols​.

Belgium’s comprehensive evaluation of climbazole underscores the EU’s commitment to safeguarding environmental health while balancing consumer safety. Stakeholders must prepare for forthcoming regulatory updates to ensure compliance.

Read the source story

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

Paint coatingsReport Suggests Restrictions on Methylenedianilines Amid Carcinogenic and Environmental Concerns

May 9, 2025

Automotive chrome platingEU Proposes Chromium(VI) REACH Restriction to Safeguard Worker Health

May 2, 2025

Industrial coatingRegulatory Action Proposed for Amine-Terminated Aliphatic Ethers

April 17, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Paint coatings

Report Suggests Restrictions on Methylenedianilines Amid Carcinogenic and Environmental Concerns

ECHA flags methylenedianilines for potential restrictions in EU due to health and environmental risks; industry urged to monitor developments.

9

May 2025

REACH
Automotive chrome plating

EU Proposes Chromium(VI) REACH Restriction to Safeguard Worker Health

The EU's proposed Chromium(VI) restriction could reshape REACH compliance and exposure controls across industry. Learn what it means for your business.

2

May 2025

REACH
Industrial coating

Regulatory Action Proposed for Amine-Terminated Aliphatic Ethers

ECHA proposes compliance checks and future restrictions for amine-terminated aliphatic ethers. Understand how this affects your regulatory obligations.

17

Apr 2025

REACH
CLP
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy